Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aurobindo Pharma Limited
Press Release Apr 26 2025
Business
Apr 26 2025
4 min read

Press Release Apr 26 2025

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 26, 2025, titled "CuraTeQ Biologics s.r.o, a wholly owned step-down subsidiary of the Company, receives Positive Opinion from CHMP for Dazublys?, a Trastuzumab Biosimilar".

View Attachment